Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Merck
Healthtrust
UBS
Argus Health

Generated: May 22, 2019

DrugPatentWatch Database Preview

CREON Drug Profile

« Back to Dashboard

When do Creon patents expire, and when can generic versions of Creon launch?

Creon is a drug marketed by Abbvie and is included in one NDA. There is one patent protecting this drug.

This drug has forty-seven patent family members in twenty-two countries.

The generic ingredient in CREON is pancrelipase (amylase;lipase;protease). There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the pancrelipase (amylase;lipase;protease) profile page.

Summary for CREON
Drug patent expirations by year for CREON

US Patents and Regulatory Information for CREON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie CREON pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 020725-002 Apr 30, 2009 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Abbvie CREON pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 020725-003 Apr 30, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Abbvie CREON pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 020725-001 Apr 30, 2009 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Abbvie CREON pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 020725-004 Jul 12, 2011 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Abbvie CREON pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 020725-004 Jul 12, 2011 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Argus Health
Moodys
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.